Oncopep Completes $11 Million Series D Financing To Continue Clinical Trials And Advance Pipeline Development
Amount Raised
$11 Million
Round Type
Series D
CambridgeDescription
OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera Science and Kukje Pharma with participation from SX Company and CrystalBioScience.
Quick answer
Onco Pep, Inc raised $11 Million in a Series D round, dated December 9, 2021. Onco Pep, Inc is based in Cambridge, Maryland, United States.
- How much did Onco Pep, Inc raise?
- Onco Pep, Inc raised $11 Million in a Series D round on December 9, 2021.
- What does Onco Pep, Inc do?
- OncoPep, Inc. is developing novel immunotherapeutics to prevent the progression of cancer, extend survival, and restore the quality of life of patients.
- Where is Onco Pep, Inc based and how big is it?
- Onco Pep, Inc is based in Cambridge, Maryland, United States.
Source: Fundz verified event record.
Who to call at Onco Pep, Inc, and when
A new round usually means Onco Pep, Inc is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Onco Pep, Inc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Onco Pep, Inc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Onco Pep, Inc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Onco Pep, Inc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Onco Pep, Inc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.